Zenith Bank has disclosed that its Staff Provident Fund, which is made up of salary contributions from employees, recently bought ...
Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback